Abstract
If I look at the United Kingdom, there is no doubt that a group of patients for whom a prophylactic prevention of NSAID-induced adverse reactions seems more important than for other groups of the population. And I am fortified in my belief that the rate of adverse reactions in the elderly is probably unacceptable. I think in younger patients the rate of side effects is so low that one could never show conclusively the benefit of prevention. In the elderly this could more likely be done. In this group 2000–3000 admissions a year with serious bleeding and perforations is a relevant problem. I do not think it really matters whether they have an ulcer history or not.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Domschke, W., Dammann, H.G., Peskar, B.M., Holtermüller, K.H. (1988). Discussion Following the Report of Prof. Graham. In: Domschke, W., Dammann, H.G., Peskar, B.M., Holtermüller, K.H. (eds) Prostaglandins and Leukotrienes in Gastrointestinal Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73316-1_35
Download citation
DOI: https://doi.org/10.1007/978-3-642-73316-1_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18744-8
Online ISBN: 978-3-642-73316-1
eBook Packages: Springer Book Archive